LYB005 / Luye Group - LARVOL DELTA

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older (clinicaltrials.gov) - P2 | N=700 | Not yet recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd.

New P2 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older (clinicaltrials.gov) - P1 | N=90 | Active, not recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd. | Not yet recruiting ➔ Active, not recruiting

Enrollment closed • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections • IL4

Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older (clinicaltrials.gov) - P1 | N=90 | Not yet recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd.

New P1 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections • IL4

LYB005-CT-AUS-101: A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults (clinicaltrials.gov) - P1 | N=84 | Active, not recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd. | Not yet recruiting ➔ Active, not recruiting | Trial completion date: Apr 2025 ➔ Dec 2025 | Trial primary completion date: Feb 2025 ➔ Dec 2025

Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults (clinicaltrials.gov) - P1 | N=84 | Not yet recruiting | Sponsor: Guangzhou Patronus Biotech Co., Ltd.

New P1 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections